Survival Rate of Dental Implants Placed in Sinus Lift Performed With Two Different Grafts
Launched by GRUPO DE INVESTIGAÇÃO: CIRURGIA ORAL, PERIDONTOLOGIA, IMPLANTOLOGIA · Apr 17, 2013
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
The study will be performance in 12 patients submitted to a bilateral sinus lift procedure.
Six months after the bilateral sinus lifting performed in a randomly way, using as graft materials (100% of autologous bone graft or 100% of xenograft), will be placed 1 to 3 implants in each maxillary sinus.
Wait more six months to expose the implant. At the end of 13 months after implant placement it should be in charge.
Implant placement (6 months after sinus lift procedure):
* Both sides should be treated during the same session.
* Patients will receive 2g Amoxicillin one hour before the proc...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any partially edentulous patient having bilateral edentulism in the posterior maxillae (premolars and/or molars) with a similar degree of bone resorption requiring one to three implants at each side, being 18 years or older, and able to sign an informed consent. For all the potentially included patients preoperative CBCT (cone beam computed tomography) or CT scans and OPGs (orthopantomograph)must be obtained and attached to the files. The vertical bone height below the maxillary sinus at the implant sites must be of 1-5 mm and bone thickness at least 6 mm measured on CBCT (cone-beam computed tomography)or CT scans. Smokers will be included and patients will be grouped into: 1) non smokers; 2) light smokers ≤ 10 cigarettes/day; 3) heavy smokers ≥ 11 cigarettes/day, according to what they declare.
- Exclusion Criteria:
- • General contraindications to implant surgery.
- • Patients irradiated in the head and neck area.
- • Immunosuppressed or immunocompromised patients.
- • Patients treated or under treatment with intravenous amino-bisphosphonates.
- • Patients with untreated periodontitis.
- • Patients with poor oral hygiene and motivation.
- • Uncontrolled diabetes.
- • Pregnancy or nursing.
- • Substance abuser.
- • Psychiatric problems or unrealistic expectations.
- • Lack of opposite occluding dentition in the area intended for implant placement.
- • Patients with an acute or chronic sinusitis.
- • Patients participating in other trials, if the present protocol cannot be properly adhered too.
- • Patients referred only for implant placement.
- • Patient unable to be followed for 5 years after loading.
About Grupo De Investigação: Cirurgia Oral, Peridontologia, Implantologia
The research group specializes in oral surgery, periodontology, and implantology, focusing on advancing clinical practices and enhancing patient outcomes through rigorous scientific investigation. Comprising a multidisciplinary team of experts, the group is dedicated to exploring innovative techniques and therapies within the dental field, aiming to address critical challenges in oral health. By conducting well-designed clinical trials, they seek to contribute valuable insights to the literature and improve standards of care in dentistry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oporto, Porto, Portugal
Patients applied
Trial Officials
Francisco Correia, DDS, Msc, PhD
Principal Investigator
Universidade do Porto
Ricardo Faria Almeida, DDS, Msc, PhD
Study Director
Universidade do Porto
Antonio Campos Felino, DDS, PhD
Study Chair
Universidade do Porto
Sonia Gouveia, Phd
Study Chair
Instituto de Engenharia Eletrónica e Informática de Aveiro (IEETA/UA) and Centro de I&D em Matemática e Aplicações (CIDMA/UA), Universidade de Aveiro (UA), Portugal
Daniel H Pozza, DDS, PhD
Study Chair
Departamento de Biomedicina da Faculdade de Medicina, and Faculdade de Ciências da Nutrição e Alimentação, and I3s, Universidade do Porto, Porto, Portugal.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials